Insilicos - Life Science Software to improve human health Life
Science
Software

news releases
     
26-Dec-08: Insilicos Appoints Fraley to Senior Scientist Post
18-Dec-08: Insilicos Awarded Grant to Study Ensemble Learning Methods
05-May-08: Insilicos Awarded Grant for Life Science Computing
03-Apr-08: Insilicos Wins NIH Grant for Manufacturing
14-Jan-08: Insilicos Heart Disease Project Wins Research Funding
30-Aug-07: Insilicos Awarded $1 Million Grant for Biotech Services
30-Apr-07: Insilicos Names Heinecke to Chief Medical Advisor Post
22-Sep-06: Insilicos and GeneBio Sign Global Distribution Agreement
29-May-06: Insilicos Announces Breakthrough Proteomics Software Platform
28-Mar-06: Insilicos Announces 1000th Licensed User of InsilicosViewer
13-Mar-06: Insilicos Awarded Grant to Study Heart Disease
14-Feb-06: Insilicos CEO Erik Nilsson Interviewed
06-Feb-06: Insilicos Awarded Grant to Commercialize Proteomics Research
14-Sep-05: Insilicos announces support for biotech data format
31-Aug-05: Insilicos Announces Web Support for Biotech Tools
08-Jul-05: Insilicos appoints Teresa Skarr as Director of Regulatory Affairs
04-Jun-05: Insilicos Announces 500th Licensed User of InsilicosViewer
27-Apr-05: Insilicos Presents at Invest Northwest
31-Mar-05: Insilicos releases new version of viewer
23-Feb-05: Insilicos Awarded Proteomics Grant
14-Dec-04: Ruedi Aebersold joins Insilicos Advisory Board
01-Sep-04: InsilicosViewer in the News
15-Apr-04: Insilicos Wins NIH Grant
13-Oct-03: Insilicos Releases Beta
26-Jun-03: Insilicos Wins Grant
30-Sep-02: Insilicos Platform Project Announced
Ruedi Aebersold joins Insilicos Advisory Board
Seattle, 14 December 2004: Biomedical software firm Insilicos today announced that proteomics pioneer Ruedi Aebersold has joined Insilicos' Scientific Advisory Board.
      Prof. Aebersold is a prominent biologist, who has developed key proteomics techniques. He brings to the Advisory Board unique insights into molecular biology and proteomics.
      Insilicos' Scientific Advisory Board represents a deep and formidable understanding of modern biological research. Each member has made important contributions to the advance of biotech. "These scientists have achieved ground-breaking research in systems biology, analytical chemistry, and other areas of science," said Insilicos Chief Scientist Dr. Bryan Prazen. "Our research program benefits from their experience and cutting-edge insight."
      "We welcome Professor Aebersold to the Board," said Insilicos President Erik Nilsson. "It's an honor to have such an outstanding group of individuals on our Scientific Advisory Board. These very busy researchers view Insilicos as a good investment of their time. That's a gratifying vote of confidence in our approach."
      The Board comprises:
  • Ruedi Aebersold, Professor of Systems Biology, Institute of Biotechnology, Swiss Federal Institute of Technology, Zürich.
  • Norman Dovichi, Endowed Professor of Analytical Chemistry, University of Washington.
  • David Robinson Goodlett, Associate Professor, Department of Medicinal Chemistry, University of Washington.
  • Nels Olson, Senior Staff Scientist and Associate Director, Illumina, Inc.
  • Robert Synovec, Professor of Chemistry, University of Washington.

  • More information on Insilicos' Advisory Board can be found at www.insilicos.com/about.html
    Insilicos LLC develops life science software for pharmaceutical development, biological research and clinical diagnostics.
          For more information, visit the Insilicos web site www.insilicos.com or contact Insilicos at info@insilicos.com. 'Insilicos' and 'Life Science Software' are trademarks of Insilicos LLC.
    copyright © 2002-2008, Insilicos LLC